Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Polymyalgia rheumatica, Red blood cell sedimentation rate
Clinical narrative: Polymyalgia Rheumatica - Diagnosed by Dr. on 05May2023/ Hips began hurting/ SED Rate Blood test: 21Apr2023: 19mm/h (High); 31May2023: 5mm/h; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 68-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Dec2022 as dose 3 (booster), single (Lot number: GJ6743) at the age of 68 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Factor V Leiden", start date: 11Jul2014 (ongoing), notes: Diagnosed-11Jul2014 after basketball pole fell on Rt foot; Dec-diagnosed with blood clot in Rt leg. Concomitant medication(s) included: AMLODIPINE (ongoing); LOSARTAN (ongoing); SIMVASTATIN (ongoing); VITAMIN D3 (ongoing); PROLIA, start date: Jun2021 (ongoing); XARELTO, start date: Mar2021 (ongoing). Vaccination history included: flu (Vaccine name: Flu, Route: Injection, Anatomical location: Right Arm, No of previous doses: Every year), administration date: 24Oct2022, when the patient was 68-year-old, for Immunization; BNT162b2 (DOSE 1, SINGLE, Batch/ Lot number not reported), administration date: 05Feb2021, when the patient was 66-year-old, for COVID-19 immunization, reaction(s): "Blood Clots Lungs"; BNT162b2 (DOSE 2, SINGLE, Batch/ Lot number not reported), administration date: 26Feb2021, when the patient was 66-year-old, for COVID-19 immunization, reaction(s): "Blood Clots Lungs"; Shingrix (Vaccine name: Shingrix 2nd dose, Route: Injection, Anatomical location: Right Arm, No of previous doses: 1 dose), administration date: Sep2022, when the patient was 68 years old, for Immunization; Shingrix (Shingrix 1st dose), for Immunization. The following information was reported: POLYMYALGIA RHEUMATICA (medically significant) with onset 08Jan2023, outcome "not recovered", described as "Polymyalgia Rheumatica - Diagnosed by Dr. on 05May2023/ Hips began hurting/ SED Rate Blood test: 21Apr2023: 19mm/h (High); 31May2023: 5mm/h". The event "polymyalgia rheumatica - diagnosed by dr. on 05may2023/ hips began hurting/ sed rate blood test: 21apr2023: 19mm/h (high); 31may2023: 5mm/h" required physician office visit. The patient underwent the following laboratory tests and procedures: Red blood cell sedimentation rate: (21Apr2023) 19 mm/h, notes: high; (31May2023) 5 mm/h. Therapeutic measures were taken as a result of polymyalgia rheumatica.  Clinical Course: The event information was reported as follows: Polymyalgia Rheumatica, Hips began hurting - Date started: 08Jan2023, did not require admission to hospital, treatment was received, patient still experiencing the events. Diagnosed by Dr. (Name withheld) 05May2023. Began 15mgs of prednisone after Polymyalgia Rheumatica diagnosis. Blood Test was taken to check Sed rate (on 21Apr2023) - Results: 19 mm/h; On 31May2023 blood test SED rate after treatment. 5 mm/h. AE did not require visit to Emergency room. Polymyalgia Rheumatica caused visit to Physician Office. Patient had no known family history of Polymyalgia Rheumatica. There were no predisposing factors. No culture was performed.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300136857 same patient, reporter, same drug, different dose and event;US-PFIZER INC-202300272236 same patient, reporter, same drug, different dose and event;